AJR Am J Roentgenol

1. KIM TH, Woo S, Ebrahimzadeh S, Mclnnes MDF, et al
   Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
   AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27989.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. WONG F
   The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?
   Am J Gastroenterol. 2022;117:1242-1243.
   

   >> Share

   
   
3. DANIELSEN KV, Wiese S, Busk T, Nabilou P, et al
   Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study.
   Am J Gastroenterol. 2022;117:1269-1278.
   

   >> Share

   
   

   
   Anticancer Res

4. NOMURA Y, Akiba J, Yano H, Akagi Y, et al
   Fatty Liver Does Not Increase the Risk of Postoperative Liver Damage Following Hepatectomy.
   Anticancer Res. 2022;42:4159-4164.
   

   >> Share

   
   
5. JU M, Aoyama T, Komori K, Tamagawa H, et al
   The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
   Anticancer Res. 2022;42:3929-3935.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. HU X, Pan H, Zhou S, Pang Q, et al
   HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression.
   Biochem Biophys Res Commun. 2022;623:111-119.
   

   >> Share

   
   
7. MAO X, Wu D, Xu N, Wang J, et al
   The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
   Biochem Biophys Res Commun. 2022;621:25-31.
   

   >> Share

   
   

   
   BMC Cancer

8. KANNO H, Hisaka T, Akiba J, Hashimoto K, et al
   C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
   BMC Cancer. 2022;22:839.
   

   >> Share

   
   
9. GUAN R, Zou J, Mei J, Deng M, et al
   Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RTqPCR validation.
   BMC Cancer. 2022;22:830.
   

   >> Share

   
   

   
   BMC Gastroenterol

10. YANG C, Chen Y, Wang C, Liu J, et al
    Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation.
    BMC Gastroenterol. 2022;22:363.
    

    >> Share

    
    
11. ALKHOURI N, Almomani A, Le P, Payne JY, et al
    The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
    BMC Gastroenterol. 2022;22:366.
    

    >> Share

    
    
12. ZHANG L, Lin JB, Jia M, Zhang CC, et al
    Clinical and imaging features preoperative evaluation of histological grade and microvascular infiltration of hepatocellular carcinoma.
    BMC Gastroenterol. 2022;22:369.
    

    >> Share

    
    

    
    Endoscopy

13. BORAHMA M, Jebari Y, Chabib FZ, Lagdali N, et al
    Endoscopic treatment of a liver hydatid cyst with biliary rupture.
    Endoscopy. 2021 Sep 27. doi: 10.1055/a-1625-4316.
    

    >> Share

    
    

    
    Eur Radiol

14. KIM TH, Lee JM, Lee DH, Joo I, et al
    Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Eur Radiol. 2022 Jul 30. pii: 10.1007/s00330-022-08991.
    

    >> Share

    
    

    
    Gut

15. LAUER GM
    Omics studies in gastroenterological and hepatological patient populations: current impact and future promise exemplified by a large study of HCV-infected livers.
    Gut. 2022 Aug 1. pii: gutjnl-2022-327761. doi: 10.1136/gutjnl-2022-327761.
    

    >> Share

    
    

    
    Hepatology

16. SUN N, Zhang C, Lee YT, Tran BV, et al
    HCC EV ECG Score: An Extracellular Vesicle-based Protein Assay for Detection of Early-Stage Hepatocellular Carcinoma.
    Hepatology. 2022 Jul 31. doi: 10.1002/hep.32692.
    

    >> Share

    
    
17. PENUELAS-HARO I, Espinosa-Sotelo R, Crosas-Molist E, Herranz-Iturbide M, et al
    The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing hepatocellular carcinoma progression.
    Hepatology. 2022 Aug 3. doi: 10.1002/hep.32702.
    

    >> Share

    
    
18. VIZZUTTI F, Celsa C, Calvaruso V, Enea M, et al
    Mortality after transjugular intrahepatic portosystemic shunt in older adult cirrhotic patients: a validated prediction model.
    Hepatology. 2022 Aug 3. doi: 10.1002/hep.32704.
    

    >> Share

    
    
19. LIANG B, Wang H, Qiao Y, Wang X, et al
    Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation driven hepatocarcinogenesis.
    Hepatology. 2022 Aug 3. doi: 10.1002/hep.32693.
    

    >> Share

    
    

    
    Indian J Gastroenterol

20. DE A, Kumari S, Kaur A, Singh A, et al
    Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis.
    Indian J Gastroenterol. 2022 Jul 19. pii: 10.1007/s12664-022-01255.
    

    >> Share

    
    

    
    Int J Cancer

21. HANG D, Yang X, Lu J, Shen C, et al
    Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts.
    Int J Cancer. 2022 Jul 29. doi: 10.1002/ijc.34229.
    

    >> Share

    
    

    
    J Clin Oncol

22. PENG Z, Fan W, Zhu B, Wang G, et al
    Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
    J Clin Oncol. 2022 Aug 3:JCO2200392. doi: 10.1200/JCO.22.00392.
    

    >> Share

    
    

    
    J Gastroenterol

23. ZHOU Q, Wang X, Li R, Wang C, et al
    Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
    J Gastroenterol. 2022 Aug 3. pii: 10.1007/s00535-022-01910.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

24. KIM HJ, Park SJ, Park HK, Byun DW, et al
    Association of thyroid autoimmunity with nonalcoholic fatty liver disease in euthyroid middle-aged subjects: A population-based study.
    J Gastroenterol Hepatol. 2022;37:1617-1623.
    

    >> Share

    
    
25. HA Y, Chon YE, Kim MN, Lee JH, et al
    Gamma-glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2022;37:1624-1632.
    

    >> Share

    
    
26. ZHANG H, Wang Y, Chen C, Wang B, et al
    Non-alcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes.
    J Gastroenterol Hepatol. 2022;37:1633-1640.
    

    >> Share

    
    
27. POHL K, Moodley P, Dhanda A
    The effect of increasing intestinal short-chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: A systematic review.
    J Gastroenterol Hepatol. 2022;37:1498-1506.
    

    >> Share

    
    

    
    Oncogene

28. YING C, Jin C, Zeng S, Chao M, et al
    Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function.
    Oncogene. 2022;41:3886-3897.
    

    >> Share

    
    
29. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Correction: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2022 Jul 27. pii: 10.1038/s41388-022-02421.
    

    >> Share

    
    

    
    PLoS One

30. GLOWCZYNSKA R, Borodzicz-Jazdzyk S, Peller M, Raszeja-Wyszomirska J, et al
    Chronotropic incompetence in end-stage liver disease.
    PLoS One. 2022;17:e0270784.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

31. CHAN CY, Chiu DK, Yuen VW, Law CT, et al
    CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2022;119:e2119514119.
    

    >> Share

    
    
32. KE H, Guay KP, Flotte TR, Gierasch LM, et al
    Secretion of functional alpha1-antitrypsin is cell type dependent: Implications for intramuscular delivery for gene therapy.
    Proc Natl Acad Sci U S A. 2022;119:e2206103119.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

33. NEHLSEN AD, Sindhu KK, Wolken T, Khan F, et al
    Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.
    Radiol Imaging Cancer. 2022;4:e210100.
    

    >> Share

    
    

    
    Transplant Proc

34. ZAN X, Fan K, Chen K, Zhi Y, et al
    Activation of GPR81 Aggravates Remote Organ Injury During Hepatic Ischemia-Reperfusion Injury.
    Transplant Proc. 2022 Jul 25. pii: S0041-1345(22)00432.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share